Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 15/20 | 0.67 |
| ▸ | SLC2A3 | P11169 | 14/20 | 0.61 |
| ▸ | SLC2A4 | P14672 | 13/20 | 0.61 |
| ▸ | SLC2A2 | P11168 | 6/20 | 0.58 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18320705 | 0.92 | SLC2A1 (0.76) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18320982 | 0.90 | SLC2A1 (0.65) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18320819 | 0.86 | SLC2A1 (0.66) | SLC2A1SLC2A3SLC2A4SLC2A2TP53 | |
| SCHEMBL16855671 | 0.86 | SLC2A1 (0.75) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18320673 | 0.85 | SLC2A1 (0.65) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18320586 | 0.85 | SLC2A1 (0.68) | SLC2A1SLC2A3SLC2A4SLC2A2TP53 | |
| SCHEMBL18320799 | 0.84 | SLC2A1 (0.72) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18320793 | 0.84 | SLC2A1 (0.84) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL16832934 | 0.84 | SLC2A1 (0.81) | SLC2A1SLC2A3SLC2A4SLC2A2TP53 | |
| SCHEMBL16832385 | 0.83 | SLC2A1 (0.70) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016202898-A1 | GLUCOSE TRANSPORT INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-12-22 | — | — | WO | claimed |